Founded by the Factor team, Exacis develops advanced cellular therapeutics to deliver potent, targeted, effective cell therapies to harness the human immune system and cure cancer. Exacis has in-licensed a highly refined and next-generation set of technologies, tools and cell lines, and know-how based upon years of scientific work performed by the Factor Bioscience team.